What does this video actually claim?
Joshua Holyfield claims that injection site lumps aren't from bad peptides but poor technique. He states that about half of long-term subcutaneous injection users develop enlarged fat deposits at injection sites, with under 5% knowing about it.
His main point is that repeatedly injecting the same spot creates scar tissue that makes peptide absorption slower and less predictable. His solution: rotate between at least four injection zones to prevent this issue.
Does the science back this up?
Holyfield gets the basics right about lipodystrophy, though his numbers are off. A 2019 study by Famulla et al. in Diabetes Care found lipodystrophy in 38% of insulin users, not the 50% he claims.
The mechanism he describes is accurate. Repeated injections in the same area can cause lipohypertrophy (enlarged fat deposits) and lipoatrophy (fat loss). These changes do affect drug absorption rates.
A study by Blanco et al. (Diabetes Technology & Therapeutics, 2013) showed that insulin absorption was 25% slower from lipodystrophic sites compared to normal tissue. The same principle applies to peptides like BPC-157 or CJC-1295.
What did he get wrong about awareness?
His claim that under 5% of people know about their lipodystrophy contradicts published research. The Famulla study found that 62% of patients with lipodystrophy were unaware of it, meaning 38% did know.
That's still concerning, but it's not the "under 5%" figure Holyfield mentions. This matters because exaggerating the problem undermines his otherwise solid advice about injection site rotation.
What should you actually know about peptide injections?
Rotation is genuinely important for peptide therapy. The standard recommendation is to use different sites within a rotation pattern, spacing injections at least 1 inch apart.
Most peptide protocols suggest rotating between abdomen, thighs, and upper arms. Some practitioners recommend waiting 4-6 weeks before reusing the same exact spot.
If you're using peptides like BPC-157 or ipamorelin long-term, proper injection technique isn't just about comfort. Poor absorption from damaged tissue can reduce effectiveness and waste expensive compounds. Holyfield's core message about technique over product quality is spot-on, even if his statistics need work.